Abstract:Objective To analyze the correlation between preoperative multimodal ultrasound features and recurrence risk of breast cancer and to explore its value. Methods A total of 286 cases (286 lesions) with breast cancer patients who underwent surgery in Mudan People’s Hospital of Heze City, Shandong Province from January 2020 to January 2023 were selected. They were divided into training set (200 cases) and validation set (86 cases) according to the ratio of 7∶3. The training set was divided into high risk group (68 cases) and a low-medium risk group (132 cases) according to the Guidelines and Norms for Diagnosis and Treatment of Breast Cancer of the Chinese Anti-Cancer Association 2021 Edition. The factors influencing the risk of breast cancer recurrence after surgery were analyzed and the prediction model of nomogram was established. The performance of the model was evaluated by receiver operating characteristic curve and calibration curve. Results There was no significant difference in general data between the training set and verification set (P>0.05). TNM stage, pathological grade, lymph node metastasis, tumor diameter, boundary, hyperechoic halo, internal echo, blood flow grade, and elastic score were significantly different between high risk group and low-medium risk group (P<0.05). Tumor diameter (OR=1.428), boundary (OR=3.425), hyperechoic halo (OR=3.300), internal echo (OR=9.631), and blood flow grade (OR=1.725) were independent risk factors for postoperative recurrence of breast cancer patients (P<0.05). Based on this, a nomogram prediction model was constructed. The area under the curve (AUC) in the training set was 0.832, and the AUC in verification set was 0.800, which showed good performance. Calibration curve consistency was high. Conclusion It is of high practical value to construct a nomogram model for predicting the recurrence risk of breast cancer based on preoperative multimodal ultrasound.
纪东露. 术前多模态超声对乳腺癌术后复发风险的预测价值[J]. 中国医药导报, 2023, 20(36): 112-116.
JI Donglu. Predictive value of preoperative multimodal ultrasound for postoperative recurrence risk of breast cancer. 中国医药导报, 2023, 20(36): 112-116.